View in EDS

Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.

Saved in:
Bibliographic Details
Title: Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.
Authors: Rausch C; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich. Electronic address: Christian.Rausch@med.uni-muenchen.de., Schwicht C; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Doedens D; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Forstpointner R; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Westphalen CB; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Heinemann V; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 37-39. Date of Electronic Publication: 2022 Aug 12.
Publication Type: Letter
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35970034
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rausch+C%22">Rausch C</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich. Electronic address: Christian.Rausch@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Schwicht+C%22">Schwicht C</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.<br /><searchLink fieldCode="AU" term="%22Doedens+D%22">Doedens D</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.<br /><searchLink fieldCode="AU" term="%22Forstpointner+R%22">Forstpointner R</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.<br /><searchLink fieldCode="AU" term="%22Westphalen+CB%22">Westphalen CB</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.<br /><searchLink fieldCode="AU" term="%22Heinemann+V%22">Heinemann V</searchLink>; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2022 Oct; Vol. 174, pp. 37-39. <i>Date of Electronic Publication: </i>2022 Aug 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35970034
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2022.07.013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 37
    Titles:
      – TitleFull: Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rausch C
      – PersonEntity:
          Name:
            NameFull: Schwicht C
      – PersonEntity:
          Name:
            NameFull: Doedens D
      – PersonEntity:
          Name:
            NameFull: Forstpointner R
      – PersonEntity:
          Name:
            NameFull: Westphalen CB
      – PersonEntity:
          Name:
            NameFull: Heinemann V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 174
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1